Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunology and lung cancer

E C Holmes

    The Annals of Thoracic Surgery
    |March 1, 1976
    PubMed
    Summary

    Lung cancer is a leading cause of cancer death. Immunotherapy may enhance tumor immunity and serve as an effective treatment when combined with surgery for lung cancer patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reagent contamination in viromics: all that glitters is not gold.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
    Same author

    Experimental Verification of Seed Transmission of Zucchini yellow mosaic virus.

    Plant disease·2019
    Same author

    Transgenic Virus Resistance in Crop-Wild Cucurbita pepo Does Not Prevent Vertical Transmission of Zucchini yellow mosaic virus.

    Plant disease·2019
    Same author

    Establishment and cryptic transmission of Zika virus in Brazil and the Americas.

    Nature·2017
    Same author

    Phylogenetic Diversity of Koala Retrovirus within a Wild Koala Population.

    Journal of virology·2016
    Same author

    Analysis of viral (zucchini yellow mosaic virus) genetic diversity during systemic movement through a Cucurbita pepo vine.

    Virus research·2014

    Area of Science:

    • Oncology
    • Immunology

    Background:

    • Lung cancer is the leading cause of cancer-related mortality in the United States.
    • Current treatments, including surgical resection, offer limited five-year survival rates (25%).
    • Patients with lung cancer often exhibit an immunosuppressed state, yet their tumors possess tumor-associated antigens.

    Purpose of the Study:

    • To review the fundamental principles of tumor immunology.
    • To emphasize the specific immunological aspects of lung cancer.
    • To explore the potential application of immunotherapy as an adjuvant therapy for lung cancer.

    Main Methods:

    • Literature review of tumor immunology principles.
    • Focus on the immunological characteristics of lung tumors.
    • Discussion of immunotherapy's role in augmenting tumor immunity.

    Main Results:

    • Lung cancer patients are frequently immunosuppressed.
    • Pulmonary tumors express tumor-associated antigens.
    • Immunotherapy has shown potential in other cancers as a surgical adjuvant.

    Conclusions:

    • Understanding tumor immunology is crucial for advancing lung cancer treatment.
    • Immunotherapy holds promise as an adjunct to surgical treatment for lung cancer.
    • Further research into immunotherapy applications could improve lung cancer survival rates.

    Related Experiment Videos